Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

The Lancet: March 25, 2008

The Lancet: March 25, 2008

FromThe Lancet in conversation with


The Lancet: March 25, 2008

FromThe Lancet in conversation with

ratings:
Length:
13 minutes
Released:
Mar 25, 2008
Format:
Podcast episode

Description

Josef Smolen from the Medical University of Vienna, Austria, discusses in this week's podcast how the monoclonal antibody tocilizumab could be effective in treating rheumatoid arthritis. Tocilizumab blocks interleukin 6, a pro-inflammatory cytokine involved in the biological process behind rheumatoid arthritis
Released:
Mar 25, 2008
Format:
Podcast episode

Titles in the series (100)

Our Editors and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.